BMS could soon face competition in the HCM space as Cytokinetics awaits a marketing application decision from the FDA for ...

The US Food and Drug Administration (FDA) has granted approval for Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in ...

Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive ...

According to analysts at BMO Capital Markets, non-obstructive hypertrophic cardiomyopathy would have meant a $1.3 billion ...

Bench applauds baseball's efforts at BMS ...

BMS urges Labour Minister to enhance ESI wage ceiling, stop contractual appointments, upgrade medical facilities for workers.

Following the success of the first-ever instalment of the Sarona Kalahari 1000 Race, the Botswana Motor Sport (BMS) is open to hosting more races of this magnitude.

Bristol-Myers Squibb has claimed its second FDA approval in the space of a few days for its immuno-oncology combination of ...

The result is a major disappointment for BMS as it effectively cuts the potential market for Camzyos in half. Sales of the ...

A New York City federal court has dismissed a proposed class-action lawsuit against Bristol Myers Squibb that accused the ...

The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action ...

AI BMS Market is Segmented by Type (LV BMS, HV BMS), by Application (Consumer Electronics, Automobile). The Global Market for ...